EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Exosomes and Small Extracellular Vesicles as an Alternative to Mesenchymal Stromal Cell Therapy in Knee Osteoarthritis: From Biological Rationale to Clinical Evidence

Mahdi Al-Jeabory, Jaroslaw Pecold, Maciej Maslyk iD, Michal Pruc iD, Karolina Gromek, Robert Weglowski, Lukasz Szarpak iD

International Journal of Molecular Sciences · 23.04.2026 · 27 (9) · 3737

DOI: 10.3390/ijms27093737 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.04.2026. Verfasst von Mahdi Al-Jeabory und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Trauma and Orthopedic Surgery, Silesian Center for Rheumatology, 43-450 Ustron, Poland. Hauptthemen laut MEDLINE: Exosomes, Extracellular Vesicles, Osteoarthritis, Knee, Mesenchymal Stem Cell Transplantation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Knee osteoarthritis (KOA) is a leading cause of pain and disability worldwide, and current treatments remain largely symptomatic, with no disease-modifying therapy established for routine use. This narrative review evaluates extracellular vesicles (EVs) as biological nanocarriers and a cell-free alternative to mesenchymal stromal cell therapy for KOA by examining the biological rationale, preclinical evidence, clinical studies, and current methodological and regulatory requirements. Preclinical findings indicate that EVs may exert immunomodulatory, anti-inflammatory, and chondroprotective effects, supporting their potential to influence joint homeostasis. The review also summarizes current recommendations for EV nomenclature, characterization, and quality control in accordance with the Minimal Information for Studies of EVs 2023 guidelines and highlights key translational challenges, including scalable manufacturing, potency assessment, and regulatory compliance. Clinical evidence to date suggests a favorable safety profile, but efficacy data remain limited and inconsistent; a randomized placebo-controlled trial showed no superiority over placebo, whereas small early human studies suggested possible benefit in selected cases. Overall, EVs represent a promising cell-free strategy for KOA, but current evidence is insufficient to support routine clinical use, emphasizing the need for standardized production, validated potency assays, and robust randomized clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesExtracellular VesiclesOsteoarthritis, KneeMesenchymal Stem Cell TransplantationHumansAnimalsMesenchymal Stem Cells

Stichwörter der Autor:innen

GMP manufacturingKnee osteoarthritisbiological nanocarriersextracellular vesiclespotency assaysquality controlscalable productionsmall extracellular vesicles

Autor:innen und Institutionen

  • Department of Trauma and Orthopedic Surgery, Silesian Center for Rheumatology, 43-450 Ustron, Poland.
  • Clinical Department of Orthopedics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 41-800 Katowice, Poland.
  • Department of Trauma and Orthopedic Surgery, Ruda Slaska City Hospital, 41-793 Ruda Slaska, Poland.
  • Institute of Biological Science, The John Paul II Catholic University of Lublin, 20-950 Lublin, Poland.
  • Institute of Medical Sciences, The John Paul II Catholic University of Lublin, 20-950 Lublin, Poland.
  • Clinical Department of Trauma and Orthopedic Surgery, The John Paul II Catholic University of Lublin, 21-300 Radzyn Podlaski, Poland.

ORCID-Profile: Maciej Maslyk, Michal Pruc, Lukasz Szarpak

Zitieren

APA

Al-Jeabory, M., Pecold, J., Maslyk, M., Pruc, M., Gromek, K., Weglowski, R., & Szarpak, L. (2026). Exosomes and Small Extracellular Vesicles as an Alternative to Mesenchymal Stromal Cell Therapy in Knee Osteoarthritis: From Biological Rationale to Clinical Evidence. International Journal of Molecular Sciences, 27(9), 3737. https://doi.org/10.3390/ijms27093737

Vancouver

Al-Jeabory M, Pecold J, Maslyk M, Pruc M, Gromek K, Weglowski R, et al. Exosomes and Small Extracellular Vesicles as an Alternative to Mesenchymal Stromal Cell Therapy in Knee Osteoarthritis: From Biological Rationale to Clinical Evidence. International Journal of Molecular Sciences. 2026;27(9):3737. doi:10.3390/ijms27093737

BibTeX
@article{AlJeabory2026,
  author = {Al-Jeabory, Mahdi and Pecold, Jaroslaw and Maslyk, Maciej and Pruc, Michal and Gromek, Karolina and Weglowski, Robert and Szarpak, Lukasz},
  title = {Exosomes and Small Extracellular Vesicles as an Alternative to Mesenchymal Stromal Cell Therapy in Knee Osteoarthritis: From Biological Rationale to Clinical Evidence},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {9},
  pages = {3737},
  doi = {10.3390/ijms27093737}
}
Kostenlos starten →